INTEGRATED CORE STRATEGIES (US) LLC - 14 Jan 2025 SCHEDULE 13G Report for Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (ENTA)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share
Symbol
ENTA
Shares outstanding
21,265,738 shares
Disclosed Ownership
1,382,273 shares
Ownership
6.5%
Form type
SCHEDULE 13G
Filing time
22 Jan 2025, 16:01:51 UTC
Date of event
14 Jan 2025
Next filing
13 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 6.5% ownership in Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (ENTA) on 14 Jan 2025."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (ENTA).
  • Disclosed ownership: 6.5%.
  • Date of event: 14 Jan 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 22 Jan 2025, 16:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 5.3% 1,125,777 0 1,125,777 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 6.5% 1,382,273 0 1,382,273 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 6.5% 1,382,273 0 1,382,273 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 6.5% 1,382,273 0 1,382,273 /s/ Israel A. Englander Israel A. Englander

Sponsored